Skip to content

Drug interactions

Fostemsavir + Memantine-donepezil

Severity: Minor

Fostemsavir and Memantine-donepezil: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Donepezil can prolong the QT interval, and fostemsavir has caused QT prolongation at supratherapeutic doses. At the recommended dose the effect of fostemsavir is small, so the combined risk is modest but may matter in patients with other arrhythmia risk factors.

What this interaction means in plain words

Fostemsavir and Memantine-donepezil have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fostemsavir belongs to Anti Virals; Memantine-donepezil belongs to Central Nervous System.

Evidence level: Low

Why it happens

Potential additive effect on cardiac repolarization (QT prolongation).

What to do

No routine dose change is needed at recommended doses. Consider an ECG in patients with existing QT risk, bradycardia or electrolyte disturbances.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fostemsavir and Memantine-donepezil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fostemsavir with Memantine-donepezil?

MediHelp rates the interaction as minor. Fostemsavir and Memantine-donepezil have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Donepezil can prolong the QT interval, and fostemsavir has caused QT prolongation at supratherapeutic doses. At the recommended dose the effect of fostemsavir is small, so the combined risk is modest but may matter in patients with other arrhythmia risk factors.

How serious is the interaction between Fostemsavir and Memantine-donepezil?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed at recommended doses. Consider an ECG in patients with existing QT risk, bradycardia or electrolyte disturbances.

What other medicines interact with Memantine-donepezil?

MediHelp also lists interactions of Memantine-donepezil with, for example, Dronedarone, Thioridazine, Amantadine. The full list is on the Memantine-donepezil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in